Sleep Onset Insomnia Clinical Trial
— NoiseOfficial title:
Effect of Continuous Background Noise at Specific Frequencies on Objective and Subjective Sleep Quality
Verified date | May 2018 |
Source | Brigham and Women's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Insufficient and low-quality sleep is a major public health problem that has been linked to
motor vehicle crashes, industrial disasters, and medical and other occupational errors.
Persons experiencing sleep insufficiency are also more likely to suffer from chronic diseases
such as hypertension, diabetes, depression, and obesity, as well as from cancer, increased
mortality, and reduced quality of life and productivity.
The number of people using sleep-inducing drugs to increase or improve sleep is steadily
increasing in the last few decades; however, the side effects of these therapies often
outweigh the benefits.
A few small trials and anecdotal findings suggest that continuous background (pink or white)
noise overnight can improve sleep quality, increase acoustic arousal threshold, and reduce
sleep onset latency.
In an attempt to find new, alternative solutions to increase sleep quality in people
suffering from insomnia, the investigators would like to test the effect of surrounding
filtered white noise on sleep onset latency and subjective sleep quality in healthy subjects.
Status | Completed |
Enrollment | 20 |
Est. completion date | February 2017 |
Est. primary completion date | February 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Age between 21 and 60 Exclusion Criteria: - Any sleep disorder - Use of hypnotics |
Country | Name | City | State |
---|---|---|---|
United States | Sleep Disorders Research Program Brigham and Women's Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Brigham and Women's Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sleep Onset Latency (Mins) | time from lights out to the first epoch of stage 2 NREM sleep | 1 night | |
Secondary | Subjective Sleep Quality (VAS) | subjective sleep quality was assessed in the morning with a visual analog scale (VAS) ranging from 1 (worse quality) to 10 (best quality) | 1 night |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01393574 -
Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties
|
Phase 4 |